These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17555418)

  • 21. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study.
    Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F
    Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
    Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H;
    Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.
    Nunes T; Barreiro-de Acosta M; Nos P; Marin-Jiménez I; Bermejo F; Ceballos D; Iglesias E; Gomez-Senent S; Torres Y; Ponferrada A; Arevalo JA; Hernandez V; Calvet X; Ginard D; Monfort D; Chaparro M; Manceñido N; Domínguez-Antonaya M; Villalón C; Perez-Calle JL; Muñoz C; Nuñez H; Carpio D; Aramendiz R; Bujanda L; Estrada-Oncins S; Hermida C; Barrio J; Casis MB; Dueñas-Sadornil MC; Fernández L; Calvo-Cenizo MM; Botella B; de Francisco R; Ayala E; Sans M;
    J Crohns Colitis; 2010 Dec; 4(6):629-36. PubMed ID: 21122572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.
    Bossa F; Latiano A; Rossi L; Magnani M; Palmieri O; Dallapiccola B; Serafini S; Damonte G; De Santo E; Andriulli A; Annese V
    Am J Gastroenterol; 2008 Oct; 103(10):2509-16. PubMed ID: 18721243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
    Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
    J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB; Wedel MK; Xia S; Baker BF
    Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach.
    Mulder CJ; Endert E; van der Heide H; Houthoff HJ; Wiersinga W; Wiltink EH; Tytgat GN
    Neth J Med; 1989 Aug; 35(1-2):18-24. PubMed ID: 2779692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX
    Barberio B; Marsilio I; Buda A; Bertin L; Semprucci G; Zanini A; Crepaldi M; Zingone F; Savarino E
    Therap Adv Gastroenterol; 2023; 16():17562848231188549. PubMed ID: 37538919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will a 5-ASA a day keep the cancer (and dysplasia) away?
    Rubin DT; Lashner BA
    Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of distal ulcerative colitis: frequently asked questions analysis.
    James SL; Irving PM; Gearry RB; Gibson PR
    Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
    Bitton A
    Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of beclomethasone dipropionate in the treatment of ulcerative colitis.
    Rizzello F; Mazza M; Salice M; Calabrese C; Calafiore A; Campieri M; Gionchetti P
    Expert Opin Drug Saf; 2018 Sep; 17(9):963-969. PubMed ID: 30101623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study.
    Rizzello F; Gionchetti P; Galeazzi R; Novelli G; Valpiani D; D'Arienzo A; Manguso F; Castiglione G; Varoli G; Campieri M
    Adv Ther; 2001; 18(6):261-71. PubMed ID: 11841196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.
    Yen EF; Kane SV; Ladabaum U
    Am J Gastroenterol; 2008 Dec; 103(12):3094-105. PubMed ID: 18775007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis.
    Mackowiak JI
    Manag Care Interface; 2006 Oct; 19(10):39-46, 56. PubMed ID: 17117598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.